204 related articles for article (PubMed ID: 29846357)
1. Seroprevalence of Hepatitis B Among HIV-infected Children and Adolescents Receiving Antiretroviral Therapy in the TREAT Asia Pediatric HIV Observational Database.
Aurpibul L; Kariminia A; Vibol U; Fong MS; Le ON; Hansudewechakul R; Bunupuradah T; Kurniati N; Chokephaibulkit K; Kumarasamy N; Wati DK; Yusoff NKN; Razali KAM; Nallusamy RA; Sohn AH; Lumbiganon P;
Pediatr Infect Dis J; 2018 Aug; 37(8):788-793. PubMed ID: 29846357
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus seromarkers among HIV infected adults on ART: An unmet need for HBV screening in eastern Ethiopia.
Ayana DA; Mulu A; Mihret A; Seyoum B; Aseffa A; Howe R
PLoS One; 2019; 14(12):e0226922. PubMed ID: 31887187
[TBL] [Abstract][Full Text] [Related]
3. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
Zhang RF; Liu L; Zheng YF; Shen YZ; Chen J; Gu SM; Wang JR; Lu HZ
Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):189-91. PubMed ID: 23967739
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus prevalence and vaccine response in HIV-infected children and adolescents on combination antiretroviral therapy in Kigali, Rwanda.
Mutwa PR; Boer KR; Rusine JB; Muganga N; Tuyishimire D; Reiss P; Lange JM; Geelen SP
Pediatr Infect Dis J; 2013 Mar; 32(3):246-51. PubMed ID: 22976050
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, risk factors and genotypes of hepatitis B infection among HIV-infected patients in the State of MS, Central Brazil.
Freitas SZ; Soares CC; Tanaka TS; Lindenberg AS; Teles SA; Torres MS; Mello FC; Mendes-Corrêa MC; Savassi-Ribas F; Motta-Castro AR
Braz J Infect Dis; 2014; 18(5):473-80. PubMed ID: 24662138
[TBL] [Abstract][Full Text] [Related]
6. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
Gupta S; Singh S
BMC Infect Dis; 2010 Mar; 10():53. PubMed ID: 20205948
[TBL] [Abstract][Full Text] [Related]
7. Low rates of active hepatitis B and C infections among adults and children living with HIV and taking antiretroviral therapy: A multicenter screening study in Lesotho.
Amstutz A; Nsakala BL; Cheleboi M; Lejone TI; Hobbins MA; Battegay M; Klimkait T; Labhardt ND
J Med Virol; 2020 Dec; 92(12):3857-3861. PubMed ID: 32369206
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of hepatitis B virus infection markers and socio-demographic risk factors in HIV-infected patients in Southern Brazil.
Martins S; Livramento Ad; Andrigueti M; Kretzer IF; Machado MJ; Spada C; Treitinger A
Rev Soc Bras Med Trop; 2014; 47(5):552-8. PubMed ID: 25467254
[TBL] [Abstract][Full Text] [Related]
9. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
Nebbia G; Garcia-Diaz A; Ayliffe U; Smith C; Dervisevic S; Johnson M; Gilson R; Tedder R; Geretti AM
J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185
[TBL] [Abstract][Full Text] [Related]
10. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and genetic variability of occult hepatitis B virus in a human immunodeficiency virus positive patient cohort in Gondar, Ethiopia.
Patel NH; Meier-Stephenson V; Genetu M; Damtie D; Abate E; Alemu S; Aleka Y; Van Marle G; Fonseca K; Coffin CS; Deressa T
PLoS One; 2020; 15(11):e0242577. PubMed ID: 33211768
[TBL] [Abstract][Full Text] [Related]
12. Occult hepatitis B virus infection in a Kenyan cohort of HIV infected anti-retroviral therapy naïve adults.
Salyani A; Shah J; Adam R; Otieno G; Mbugua E; Shah R
PLoS One; 2021; 16(1):e0244947. PubMed ID: 33406137
[TBL] [Abstract][Full Text] [Related]
13. Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon.
Gachara G; Magoro T; Mavhandu L; Lum E; Kimbi HK; Ndip RN; Bessong PO
AIDS Res Ther; 2017 Mar; 14(1):11. PubMed ID: 28270215
[TBL] [Abstract][Full Text] [Related]
14. Development of anti-hepatitis B surface (HBs) antibodies after HBs antigen loss in HIV-hepatitis B virus co-infected patients.
Boyd A; Canini L; Gozlan J; Lascoux-Combe C; Miailhes P; Fonquernie L; Girard PM; Lacombe K
J Clin Virol; 2017 Oct; 95():55-60. PubMed ID: 28869890
[TBL] [Abstract][Full Text] [Related]
15. Overt and occult hepatitis B virus infection in adult Sudanese HIV patients.
Mudawi H; Hussein W; Mukhtar M; Yousif M; Nemeri O; Glebe D; Kramvis A
Int J Infect Dis; 2014 Dec; 29():65-70. PubMed ID: 25449238
[TBL] [Abstract][Full Text] [Related]
16. Risk of hepatitis B surface antigen seroreversion after corticosteroid treatment in patients with previous hepatitis B virus exposure.
Wong GL; Wong VW; Yuen BW; Tse YK; Yip TC; Luk HW; Lui GC; Chan HL
J Hepatol; 2020 Jan; 72(1):57-66. PubMed ID: 31499132
[TBL] [Abstract][Full Text] [Related]
17. [Significance of hepatitis B core antibody as the only marker of hepatitis B infection].
Colomina-Rodríguez J; González-García D; Burgos-Teruel A; Fernández-Lorenz N; Guerrero-Espejo A
Enferm Infecc Microbiol Clin; 2005 Feb; 23(2):80-5. PubMed ID: 15743579
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B and hepatitis C virus infections among antiretroviral-naive and -experienced HIV co-infected adults.
Manyazewal T; Sisay Z; Biadgilign S; Abegaz WE
J Med Microbiol; 2014 May; 63(Pt 5):742-747. PubMed ID: 24757219
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women.
Khamduang W; Ngo-Giang-Huong N; Gaudy-Graffin C; Jourdain G; Suwankornsakul W; Jarupanich T; Chalermpolprapa V; Nanta S; Puarattana-Aroonkorn N; Tonmat S; Lallemant M; Goudeau A; Sirirungsi W;
Clin Infect Dis; 2013 Jun; 56(12):1704-12. PubMed ID: 23487379
[TBL] [Abstract][Full Text] [Related]
20. Integrated HIV surveillance finds recent adult hepatitis B virus (HBV) transmission and intermediate HBV prevalence among military in uncharacterized Caribbean country.
O'Connor SM; Mixson-Hayden T; Ganova-Raeva L; Djibo DA; Brown M; Xia GL; Kamili S; Jacobs M; Dong M; Thomas AG; Bulterys M; Hale B
PLoS One; 2019; 14(10):e0222835. PubMed ID: 31574098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
